Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjunctive thrombolytic agents with coronary interventional techniques

S J Yakubov1, B S George, A T Chapekis

  • 1Mid West Cardiology Research Foundation, Riverside Methodist Hospital, Columbus, Ohio.

Cardiology Clinics
|November 1, 1994
PubMed
Summary

Thrombolytics are crucial for interventional procedures like PTCA and stenting. This review explores their diverse applications and summarizes key clinical trial findings regarding their use in cardiovascular interventions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abciximab readministration: results of the ReoPro Readministration Registry.

Circulation·2001
Same author

Why endovascular therapy should be utilized before surgical bypass for femoropopliteal occlusive disease.

The Journal of invasive cardiology·2001
Same author

Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter.

American heart journal·2001
Same author

Percutaneous radial approach: isn't it time we put it in its place?

The Journal of invasive cardiology·2000
Same author

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

Circulation·1998
Same author

Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.

Journal of the American College of Cardiology·1998

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • Thrombolytic agents are utilized in various interventional cardiovascular procedures.
  • Current applications include direct lytic therapy and adjunctive use with percutaneous transluminal coronary angioplasty (PTCA), directional atherectomy, and intracoronary stenting.
  • Controversy exists regarding optimal thrombolytic dosage and agent selection.

Purpose of the Study:

  • To comprehensively review the potential applications of thrombolytic therapy in interventional cardiology.
  • To synthesize findings from major clinical trials investigating thrombolytic use in these contexts.

Main Methods:

  • Literature review of interventional cardiology procedures involving thrombolytics.
  • Analysis of data from significant clinical trials on thrombolytic efficacy and safety.

Related Experiment Videos

Main Results:

  • Thrombolytics demonstrate utility across a spectrum of interventional cardiovascular treatments.
  • Evidence from major trials provides insights into the effectiveness and controversies surrounding thrombolytic dosage and choice.

Conclusions:

  • Thrombolytic therapy remains an important component of interventional cardiovascular medicine.
  • Further research and consensus are needed to standardize thrombolytic protocols for optimal patient outcomes.